https://www.selleckchem.com/pr....oducts/acss2-inhibit
© 2020 WILEY-VCH Verlag GmbH Co. KGaA, Weinheim.BACKGROUND Congenital agammaglobulinemia is the first primary immunodeficiency disorder characterized by a defect in B lymphocyte development and subsequently decreased immunoglobulin levels. These patients are prone to suffer from recurrent infections mostly involving the respiratory tract. In this study, we aimed to describe in detail respiratory tract complications as the most prominent clinical feature among agammaglobulinemic patients. METHODS A total number of 115 patie
Like
Comment
Share
